Mural Oncology plc (MURA)

Mural Oncology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	121.59	270.85	-	-
Cash & Short-Term Investments	204.7	270.85	-	-
Other Receivables	1.63	6.34	1.8	2
Receivables	1.63	6.34	1.8	2
Prepaid Expenses	6.72	0.15	2.99	2.2
Other Current Assets	-	-	0.03	0.04
Total Current Assets	213.06	277.34	4.82	4.24
Property, Plant & Equipment	19.84	24.15	28.93	30.87
Other Long-Term Assets	2.03	0.26	-	-
Total Assets	234.93	301.75	33.75	35.11
Accounts Payable	3.11	5.97	2.97	10.59
Accrued Expenses	16.17	16.95	32.75	16.74
Current Portion of Leases	5.35	6.1	5.84	5.92
Total Current Liabilities	24.63	29.02	41.56	33.25
Long-Term Leases	5.73	8.91	13.54	19.39
Other Long-Term Liabilities	-	-	0.3	0.36
Total Liabilities	30.36	37.93	55.41	52.99
Common Stock	0.17	0.17	-21.66	-17.88
Additional Paid-In Capital	297.8	294.51	-	-
Retained Earnings	-93.34	-30.86	-	-
Shareholders' Equity	204.57	263.82	-21.66	-17.88
Total Liabilities & Equity	234.93	301.75	33.75	35.11
Total Debt	11.08	15.01	19.39	25.31
Net Cash (Debt)	193.62	255.84	-19.39	-25.31
Net Cash Per Share	11.54	15.33	-1.16	-
Filing Date Shares Outstanding	17.04	16.92	16.69	-
Total Common Shares Outstanding	16.93	16.69	16.69	-
Working Capital	188.43	248.32	-36.74	-29.01
Book Value Per Share	12.09	15.81	-1.30	-
Tangible Book Value	204.57	263.82	-21.66	-17.88
Tangible Book Value Per Share	12.09	15.81	-1.30	-
Machinery	21.81	21.74	17.47	13.6
Construction In Progress	-	0.02	1.99	1.97
Leasehold Improvements	23.33	23.33	22.51	20.88

Source: S&P Capital IQ. Standard template. Financial Sources.